Chaperone-rich cell lysates, immune activation and tumor vaccination.
about
Heat shock proteins: stimulators of innate and acquired immunityEndoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccinesSignaling pathways induced by a tumor-derived vaccine in antigen presenting cellsAllogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia.Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to comeTherapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.Heat shock proteins: stress proteins with Janus-like properties in cancer.Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.Personalized dendritic cell-based tumor immunotherapy.Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer.Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development.Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine.
P2860
Q26829100-3FC9DADC-2A10-4E4E-B4D9-AF8F390D5CE0Q28084299-7F6314E2-8F93-4DC8-AB96-2032B4BB2AB9Q33895525-53FFAA68-CF4B-4B8C-9FE3-83D80842EFB9Q34667551-F1562AF5-7901-40D6-BDFF-4C8D9D0B1744Q35624884-DAD0B2BD-E449-4257-96A3-7CCD7ED32FFAQ36499222-26A0B3B2-153E-4B50-9819-8D0B53C3BA64Q37063489-6D032182-8688-4C94-98A0-2A3FC7943CFEQ37259616-64AA6F44-9820-4BF3-AE3D-6B3303C66219Q37693733-5BF80807-39DE-413D-AA7F-F17C7CD1EB4CQ38095583-A7F0C910-C4C6-4181-8CCB-5287D4BAAEAAQ38909897-1E85E9A9-0D31-4D73-A982-738E8E2F718BQ39145269-853776B0-B194-48C0-8A99-E111D7579C55Q39963921-3430AA9C-1E05-400E-898F-19D226E05A4EQ40161313-1FC1DCE1-219A-4738-9A34-DA819FB95D63Q49805006-4330ECE6-5D85-48B3-A121-FDDD5236FC62Q50891745-F726E01D-7737-488A-B19D-ED533B6D26DB
P2860
Chaperone-rich cell lysates, immune activation and tumor vaccination.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@ast
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@en
type
label
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@ast
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@en
prefLabel
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@ast
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@en
P2093
P2860
P1476
Chaperone-rich cell lysates, immune activation and tumor vaccination.
@en
P2093
Emmanuel Katsanis
Michael W Graner
P2860
P2888
P304
P356
10.1007/S00262-005-0694-1
P577
2005-05-11T00:00:00Z